UnitLevel 5Postgraduate

MPS5103 Drug design and optimisation

Faculty of Pharmacy and Pharmaceutical Sciences

MPS5103 Drug design and optimisation is a level 5, 6-credit-point, postgraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2024 in Semester 1 at Parkville. It has no prerequisites.

Credit points
6
Offered in 2024
Semester 1
Parkville
Assessment
No exam
3 tasks

This is the 2024 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review MPS5103.

Overview

This unit introduces you to pharmaceutical discovery and development, and the strategies used to optimise bioactive molecules into clinically useful drugs.

The unit will discuss the sources of bioactive molecules and the approaches used to identify small molecules that interact with a given target (hits); strategies used to optimise properties of hits to give molecules worthy of further development (leads); biological drugs; and the processes by which candidate drugs are evaluated. The unit will provide an introduction to computational modelling and discuss how computer-aided molecular modelling can be used in ligand-based and receptor-based approaches to aid drug development. Throughout the unit, you will be guided through a series of written research exercises, culminating in a comprehensive report on the design and optimisation of a contemporary drug.

Upon completing this unit, you will have a knowledge base from which you can critically evaluate the suitability of drug discovery and design approaches appropriate for different situations.

Offerings in 2024

Teaching periodCampusMode
First semesterParkvilleOn campus

Assessment

  • Workshop activities
    20%
  • Final report
    40%
  • In-semester tests
    40%

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Describe the key components and strategies of drug discovery and optimisation

  2. 2

    Utilise different computational techniques to aid the design of small molecules with good affinity for biomolecular targets

  3. 3

    Propose modifications to hit molecules necessary to map their structure-activity relationship (SAR), and guide hit-to-lead and lead-to-drug optimisation strategies

  4. 4

    Critically evaluate different drug discovery and optimisation approaches and identify the most suitable approach for a particular situation

  5. 5

    Use effective written communication skills to present informed outcomes of enquiry-based research into examples of drug design and optimisation.

Workload and teaching

  • Workshops16 hours
  • Assessments4 hours
  • Applied sessions12 hours
  • Teaching approachPeer assisted learning
  • Teaching approachCase-based teaching
  • Teaching approachProblem-based learning
  • Teaching approachActive learning
  • Teaching approachEnquiry-based learning
  • Teaching approachOnline learning
  • 36 hours of online modules
  • Eight 2-hour workshops
  • Twelve 1-hour applied sessions
  • 80 hours of independent study

Learning resources

Technology resources

This unit requires access to a laptop that meets minimum specifications. Free specialist software is available via MoVE. 

Contacts

Chief Examiners
Dr Tony Hughes
Unit Coordinators
Dr Tony Hughes

Common questions

What are the prerequisites for MPS5103?

MPS5103 has no prerequisites.

When is MPS5103 offered?

In 2024, MPS5103 runs in Semester 1 at Parkville.

Does MPS5103 have an exam?

No. MPS5103 has 3 assessment tasks and no exam.

More details

Credit points
6
Level
5
Study level
Postgraduate
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Type
Coursework
EFTSL
0.125
Student contribution
SCA Band 2
Study abroad
Not available
Handbook years
202220232024202520262027